Shares of Heat Biologics Inc (NASDAQ: HTBX), a biopharmaceutical company, experienced a strong upward momentum after the share price rallied over 61% in the last two trading sessions after recording gains of more than 26% during each of the past two consecutive trading sessions with massive number of shares exchanging hands. During the last trading session, HTBX was the top performers in the U.S. healthcare sector having gained 26% breaking the long term technical resistance level of 200-day DMA of $6.25 and closed at $6.68 while recording significant volumes of 1.3 million shares. The stock went public 13 months ago at a price of $10. The shares peaked at $14.60 in October and have eroded since then, hitting a low of $3.81 earlier this month. During the past 5-trading sessions, HTBX surged 67% while recording daily average trading volumes of 536,336 shares, while the stock accumulated over 62% in the last one month with daily average trading volume of 102,572 shares.
Company Description:
Heat Biologics Inc (NASDAQ: HTBX) is a biopharmaceutical company. The Company develops drugs to treat a variety of cancers, viral, and autoimmune diseases. Heat Biologics manufactures antibodies to treat asthma, inflammatory bowel disease, and rheumatoid arthritis.
1-Year Stock Chart:
Source: Bloomberg
